Ingevity Corporation
NYSE:NGVT
41.75 (USD) • At close December 26, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,692.1 | 1,668.3 | 1,391.5 | 1,216.1 | 1,292.9 | 1,133.6 | 972.4 | 908.3 | 968 | 1,041 | 980 | 939 |
| Cost of Revenue
| 1,220.2 | 1,098.2 | 878.7 | 750.6 | 810.9 | 716.8 | 643.4 | 633.9 | 687 | 718 | 685 | 642 |
| Gross Profit
| 471.9 | 570.1 | 512.8 | 465.5 | 482 | 416.8 | 329 | 274.4 | 281 | 323 | 295 | 297 |
| Gross Profit Ratio
| 0.279 | 0.342 | 0.369 | 0.383 | 0.373 | 0.368 | 0.338 | 0.302 | 0.29 | 0.31 | 0.301 | 0.316 |
| Reseach & Development Expenses
| 31.8 | 30.3 | 26.3 | 22.6 | 19.7 | 21.5 | 19.8 | 7.6 | 6.9 | 8 | 11 | 9 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 132.4 | 106.4 | 114 | 114 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 183.7 | 198.8 | 179.3 | 149.4 | 163.1 | 132.4 | 106.4 | 114 | 114 | 112 | 103 | 95 |
| Other Expenses
| 0 | 1.7 | -79.9 | 4.1 | 4.3 | -1 | -0.5 | 3.2 | 10 | 4 | 5 | -1 |
| Operating Expenses
| 183.7 | 229.1 | 205.6 | 172 | 182.8 | 153.9 | 126.2 | 114 | 114 | 112 | 103 | 95 |
| Operating Income
| 288.2 | 342.7 | 227.3 | 297.6 | 327.9 | 262.9 | 202.8 | 160.4 | 167 | 211 | 192 | 202 |
| Operating Income Ratio
| 0.17 | 0.205 | 0.163 | 0.245 | 0.254 | 0.232 | 0.209 | 0.177 | 0.173 | 0.203 | 0.196 | 0.215 |
| Total Other Income Expenses Net
| -298.3 | -71.4 | -144.4 | -58.4 | -71.3 | -41.1 | -28 | -73.4 | -28.8 | -8.9 | -8 | -13 |
| Income Before Tax
| -10.1 | 269.6 | 162.8 | 235.1 | 227.9 | 221.8 | 174.8 | 87 | 138 | 203 | 184 | 189 |
| Income Before Tax Ratio
| -0.006 | 0.162 | 0.117 | 0.193 | 0.176 | 0.196 | 0.18 | 0.096 | 0.143 | 0.195 | 0.188 | 0.201 |
| Income Tax Expense
| -4.7 | 58 | 44.7 | 48.9 | 44.2 | 40 | 29.8 | 42.6 | 53 | 70 | 66 | 67 |
| Net Income
| -5.4 | 211.6 | 118.1 | 181.4 | 183.7 | 169.1 | 126.3 | 35.2 | 80 | 129 | 119 | 119 |
| Net Income Ratio
| -0.003 | 0.127 | 0.085 | 0.149 | 0.142 | 0.149 | 0.13 | 0.039 | 0.083 | 0.124 | 0.121 | 0.127 |
| EPS
| -0.15 | 5.54 | 2.97 | 4.39 | 4.39 | 4.03 | 3 | 0.83 | 1.89 | 3.07 | 2.83 | 2.83 |
| EPS Diluted
| -0.15 | 5.5 | 2.95 | 4.37 | 4.35 | 3.97 | 2.97 | 0.83 | 1.89 | 3.07 | 2.83 | 2.83 |
| EBITDA
| 224.6 | 456.3 | 337.2 | 397.8 | 412.9 | 319.8 | 243.1 | 199.2 | 199.9 | 252 | 230 | 233 |
| EBITDA Ratio
| 0.133 | 0.271 | 0.242 | 0.327 | 0.319 | 0.231 | 0.208 | 0.182 | 0.219 | 0.238 | 0.235 | 0.248 |